KCNQ1 Variant V307L
Summary of observed carriers, functional annotations, and structural context for KCNQ1 V307L. Data combine curated literature, international cohorts, and gnomAD observations.
Estimated LQT1 penetrance
41%
4/11 effective observations
Total carriers
1
0 LQT1 · unaffected
Functional studies
2
Publications with functional data
Variant features alone are equivalent to phenotyping 4 individuals with LQT1 and 6 unaffected individuals.
In silico predictors
| PROVEAN | PolyPhen-2 | BLAST-PSSM | REVEL | Penetrance Density LQT1 (%) |
|---|---|---|---|---|
| -2.92 | 0.798 | 0 | 0.863 | 65 |
PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. BLAST-PSSM reflects evolutionary conservation; more negative values indicate rarer substitutions. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).
Reported carrier data
| Source | Year | Carriers | Unaffected | LQT1 | Other Disease |
|---|---|---|---|---|---|
| 30337886 | 2018 | None | None | None | None |
| 28814790 | 2017 | None | None | None | None |
| 20436212 | 2010 | None | None | None | None |
| 17905416 | 2008 | None | None | None | None |
| 15159330 | 2004 | 1 | 1 | None | 1 SQTS |
| Literature, cohort, and gnomAD | – | 1 | 0 | – | |
| Variant features alone | – | 15 | 6 | 4 | – |
Totals may differ from individual publications due to duplicate patients removed during curation.